title: Can PET data differentiate Alzheimer's disease from vascular dementia?
abstract: The present study endeavored to differentiate Alzheimer's disease (AD) from vascular dementia (VaD) by comparing the metabolic and hemodynamic parameters. Positron emission tomographic (PET) studies were carried out in 13 patients with probable AD and 20 patients with VaD. PET findings were not included in the diagnostic criteria of AD or VaD. Using oxygen-15 labeled compounds, cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO2), oxygen extraction fraction (OEF), cerebral blood volume, and vascular transit time (VTT) were measured quantitatively during the resting state. To evaluate vascular reactivity (VR), CBF was also measured during 7% CO2 inhalation. Regional CBF from the parietal cortex positively correlated with the neuropsychological scores in both AD and VaD groups. The typical parietotemporal pattern of hypoperfusion and hypometabolism was observed in the AD group, whereas the frontal lobe including the cingulate and superior frontal gyri were predominantly affected in the VaD group. The occipital cortex was preserved in both groups. A significant increase of the OEF was found in the parietotemporal areas in the AD group. No significant prolongation was seen with VTT. There was a marked difference in VR between the two groups: VR was depleted in the VaD group, whereas VR was normal in the AD group. The increased OEF with preserved vascular reserve seen in AD may implicate participation of a vascular factor in the pathogenesis of AD, possibly at the capillary level. Thus, PET provides important functional information in discriminating AD from VaD by comparing the patterns of hypoperfusion and/or hypometabolism, and in the understanding of the underlying hemodynamic pathophysiology.
authors.affiliation: Department of Neurology, Research Institute for Brain and Blood Vessels, Akita, Japan. nagata@akita-noken.go.jp
authors.forename: K
authors.initials: K
authors.lastname: Nagata
authors.forename: H
authors.initials: H
authors.lastname: Maruya
authors.forename: H
authors.initials: H
authors.lastname: Yuya
authors.forename: H
authors.initials: H
authors.lastname: Terashi
authors.forename: Y
authors.initials: Y
authors.lastname: Mito
authors.forename: H
authors.initials: H
authors.lastname: Kato
authors.forename: M
authors.initials: M
authors.lastname: Sato
authors.forename: Y
authors.initials: Y
authors.lastname: Satoh
authors.forename: Y
authors.initials: Y
authors.lastname: Watahiki
authors.forename: Y
authors.initials: Y
authors.lastname: Hirata
authors.forename: E
authors.initials: E
authors.lastname: Yokoyama
authors.forename: J
authors.initials: J
authors.lastname: Hatazawa
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000503:physiopathology; D001794:Blood Pressure; D001921:Brain / Q000098:blood supply / Q000000981:diagnostic imaging; D002302:Cardiac Output; D002560:Cerebrovascular Circulation; D015140:Dementia, Vascular / Q000000981:diagnostic imaging* / Q000378:metabolism / Q000503:physiopathology; D003937:Diagnosis, Differential; D006801:Humans; D008875:Middle Aged; D010101:Oxygen Consumption; D010104:Oxygen Radioisotopes; D014055:Tomography, Emission-Computed; D015899:Tomography, Emission-Computed, Single-Photon; D014655:Vascular Resistance
chemical_list: D010104:Oxygen Radioisotopes